NAPLES, Fla. and CAMBRIDGE, United Kingdom, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), a multi-asset, clinical stage, disease-agnostic ...
NAPLES, Fla. and CAMBRIDGE, United Kingdom - Conduit Pharmaceuticals Inc. (Nasdaq: CDT), a multi-asset clinical stage life science company with a market capitalization of $4.88 million, has announced ...
Conduit Pharmaceuticals Inc. announced a 1-for-15 reverse stock split of its common stock, approved by its board and stockholders, effective May 19, 2025. Following this split, every fifteen shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback